Spectral AI Inc. (MDAI) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Spectral AI Inc. (MDAI:NASDAQ), powered by AI.

Current Price
$1.45
P/E Ratio
-1.7
Market Cap
26M
Sector
Healthcare
What is the Spectral AI Inc. stock price forecast?

Spectral AI Inc. is currently trading at $1.45. View real-time AI analysis on Alpha Lenz.

What is Spectral AI Inc. insider trading activity?

View the latest insider trading data for Spectral AI Inc. on Alpha Lenz.

What is Spectral AI Inc.'s P/E ratio?

Spectral AI Inc.'s P/E ratio is -1.7.

Spectral AI Inc.

$1.45
NASDAQMDAI
Ask about Spectral AI Inc.'s future dividend policy...
Alpha Chat Insight

Spectral AI Inc. trades at a P/E of -1.7 (undervalued) with strong ROE of 341.9%. 3Y revenue CAGR of 24.7% highlights clear growth momentum.

Ask for details

Company Overview

Spectral AI Inc. is a cutting-edge technology company that specializes in the development of advanced imaging systems and artificial intelligence applications. The primary function of Spectral AI is to transform medical diagnostics and clinical outcomes through its proprietary technology platform, which integrates imaging technologies with deep learning algorithms. Notable within the healthcare industry, this platform is particularly impactful in the diagnosis of burn wounds and chronic wounds, offering significant advancements over traditional methods. Spectral AI's technology facilitates real-time, non-invasive assessment, potentially improving decision-making for healthcare professionals. The company's innovations cater to the needs of hospitals, clinics, and military medical services, aiming to enhance patient care efficiency and outcomes dramatically. In the financial market, Spectral AI represents a promising player in the med-tech sector, harnessing the power of AI to address complex diagnostic challenges. By narrowing the gap between technological advancements and practical medical applications, Spectral AI exemplifies the evolving role of AI in modern medicine, marking its significance as a transformative force in healthcare diagnostics on the global stage.

CEOMr. Wensheng Fan
SectorHealthcare
IndustryMedical Devices
Employees78

Company Statistics

(FY 2024)

Profile

Market Cap$26.00M
Revenue$29.58M
Shares Out0.00
Employees78

Margins

Gross44.87%
EBITDA-20.96%
Operating-22.25%
Pre-Tax-50.86%
Net-51.77%

Valuation

P/E-1.70
P/B-3.59
EV/Sales0.88
EV/EBITDA-4.12
P/FCF-2.83

Growth (CAGR)

Rev 3Yr24.74%
Rev 5YrN/A
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROA-134.42%
ROE341.85%
ROIC-106.02%

Financial Health

Cash & Cash Equivalents$5.16M
Net Debt$14.19M
Debt/Equity-266.80%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Spectral AI Inc. (Healthcare) Stock Forecast & Analysis $1.45 | Alpha Lenz